Literature DB >> 35221873

Kosaki Overgrowth Syndrome: Report of a Family with a Novel PDGFRB Variant.

Hatice Mutlu Albayrak1, Alistair D Calder2.   

Abstract

Heterozygous activating missense variants of PDGFRB are associated with the phenotype of Kosaki overgrowth syndrome (KOGS). Here, we present a family including a father and 2 siblings with a novel variant, c.2567A>T (p.Asn856Ile), localized in the cytoplasmic tyrosine kinase domain, exhibiting a KOGS phenotype. The coarsening of the facial features, enlargement of the hands/feet, and progressive scoliosis started to appear after an average age of 6. There were no signs of thin/fragile skin, premature aging appearance, myofibroma, white matter findings, and intellectual disability in any of them. Corneal pterygium and evidence of cerebral vasculopathy were only detected in the father. One sibling exhibited café-au-lait spots. Posterior fossa enlargement was revealed only in one sibling. KOGS is an extremely rare overgrowth syndrome. No familial cases of KOGS have been reported so far. Hereby, we demonstrated that the features of KOGS can show mild intrafamilial variability, and the risk of vascular complications may arise with age.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Kosaki overgrowth syndrome; PDGFRB; Scoliosis; Tyrosine kinase domain

Year:  2021        PMID: 35221873      PMCID: PMC8832207          DOI: 10.1159/000517978

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  12 in total

1.  A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome.

Authors:  Jennifer J Johnston; Monica Y Sanchez-Contreras; Kim M Keppler-Noreuil; Julie Sapp; Molly Crenshaw; NiCole A Finch; Valerie Cormier-Daire; Rosa Rademakers; Virginia P Sybert; Leslie G Biesecker
Journal:  Am J Hum Genet       Date:  2015-08-13       Impact factor: 11.025

2.  Expansion of the phenotype of Kosaki overgrowth syndrome.

Authors:  Mari Minatogawa; Toshiki Takenouchi; Yu Tsuyusaki; Fuminori Iwasaki; Tomoko Uehara; Kenji Kurosawa; Kenjiro Kosaki; Cynthia J Curry
Journal:  Am J Med Genet A       Date:  2017-06-22       Impact factor: 2.802

Review 3.  Role of platelet-derived growth factors in physiology and medicine.

Authors:  Johanna Andrae; Radiosa Gallini; Christer Betsholtz
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

Review 4.  Constitutive activation of the PI3K-AKT pathway and cardiovascular abnormalities in an individual with Kosaki overgrowth syndrome.

Authors:  Yuri A Zarate; Luigi Boccuto; Sujata Srikanth; Rini Pauly; Eylem Ocal; Tonya Balmakund; Kevin Hinkle; Vikki Stefans; Gerald B Schaefer; Ronnie Thomas Collins
Journal:  Am J Med Genet A       Date:  2019-04-02       Impact factor: 2.802

5.  Phenotype expansion and development in Kosaki overgrowth syndrome.

Authors:  P Gawliński; M Pelc; E Ciara; S Jhangiani; E Jurkiewicz; T Gambin; A Różdżyńska-Świątkowska; M Dawidziuk; Z H Coban-Akdemir; D L Guilbride; D Muzny; J R Lupski; M Krajewska-Walasek
Journal:  Clin Genet       Date:  2018-04       Impact factor: 4.438

6.  Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.

Authors:  Toshiki Takenouchi; Yu Yamaguchi; Akiko Tanikawa; Rika Kosaki; Hideyuki Okano; Kenjiro Kosaki
Journal:  J Pediatr       Date:  2014-11-18       Impact factor: 4.406

7.  Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis.

Authors:  John A Martignetti; Lifeng Tian; Dong Li; Maria Celeste M Ramirez; Olga Camacho-Vanegas; Sandra Catalina Camacho; Yiran Guo; Dina J Zand; Audrey M Bernstein; Sandra K Masur; Cecilia E Kim; Frederick G Otieno; Cuiping Hou; Nada Abdel-Magid; Ben Tweddale; Denise Metry; Jean-Christophe Fournet; Eniko Papp; Elizabeth W McPherson; Carrie Zabel; Guy Vaksmann; Cyril Morisot; Brendan Keating; Patrick M Sleiman; Jeffrey A Cleveland; David B Everman; Elaine Zackai; Hakon Hakonarson
Journal:  Am J Hum Genet       Date:  2013-05-23       Impact factor: 11.025

8.  A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib.

Authors:  Dinel Pond; Florence A Arts; Nancy J Mendelsohn; Jean-Baptiste Demoulin; Gunter Scharer; Yoav Messinger
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

9.  Reference Values for Weight, Height, Head Circumference, and Body Mass Index in Turkish Children.

Authors:  Olcay Neyzi; Rüveyde Bundak; Gülbin Gökçay; Hülya Günöz; Andrzej Furman; Feyza Darendeliler; Firdevs Baş
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12

10.  Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.

Authors:  Peter Mudry; Ondrej Slaby; Jakub Neradil; Jana Soukalova; Kristyna Melicharkova; Ondrej Rohleder; Marta Jezova; Anna Seehofnerova; Elleni Michu; Renata Veselska; Jaroslav Sterba
Journal:  BMC Cancer       Date:  2017-02-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.